Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

DPH 1,925.00 +33.00 (1.74%)
price chart
What Should Investors Know About the future of Dechra Pharmaceuticals plc's ...
Dechra Pharmaceuticals plc (LSE:DPH) is predicted to colossally grow its earnings per share by over 150% in the next 12 months.
Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after ...
Pharmaceutical giants Dechra Pharmaceuticals (LSE: DPH) and GlaxoSmithKline (LSE: GSK) took divergent paths in Monday morning business despite both releasing positive updates.
Dechra Pharmaceuticals PLC: Annual Results  PR Newswire (press release)
Dechra� Pharmaceuticals PLC Trading Update
International specialist veterinary pharmaceuticals and related products business, Dechra Pharmaceuticals PLC (Dechra or the Company) (Stock Code: Full Listing (Pharmaceuticals): DPH) issues the following unaudited Trading Update covering the half year ...
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...
Dechra Pharmaceuticals PLC (LSE: symbol DPH) announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine.
Dechra to acquire Putney, maker of generic veterinary drugs, for $200 million  dvm360
OP animal health parent leashes $200M acquisition  Kansas City Business Journal
Dechra Pharmaceuticals PLC: Half-Yearly Financial Report 2016
"All our business units are performing well, we are in the process of launching several new products, our international expansion plans are progressing as expected and we have made two strategic acquisitions.
Dechra Pharmaceuticals PLC (DPH.L) Shares Moving On Volume
Needle moving action has been spotted in Dechra Pharmaceuticals PLC (DPH.L) as shares are moving today on volatility 1.76% or $33.07 from the open.
Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra ...
One of the major concerns of investors in AstraZeneca (LSE: AZN) in recent years has been its ability to pay dividends. That's because it has been subjected to a patent cliff, where a number of key drugs have come off-patent and with the company ...
Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?
Pet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week.
Dechra� Pharmaceuticals PLC (Dechra or the Group) : Trading Update
The Board of Dechra Pharmaceuticals PLC (LSE:DPH), issues the following unaudited Trading Update ahead of the Group's half-year financial results for the period ended 31 December 2015, which will be announced on Monday, 22 February 2016.
Dechra Pharmaceuticals PLC (DPH.L) Seeing Increased Volatility in Session
Shares of Dechra Pharmaceuticals PLC (DPH.L) have seen the needle move 1.48% or 28.00 in the most recent session. The LSE listed company saw a recent bid of $1920.00 on 39226 volume.